Dnmt2/Trdmt1 as Mediator of RNA Polymerase II Transcriptional Activity in Cardiac Growth

PLoS One. 2016 Jun 6;11(6):e0156953. doi: 10.1371/journal.pone.0156953. eCollection 2016.

Abstract

Dnmt2/Trdmt1 is a methyltransferase, which has been shown to methylate tRNAs. Deficient mutants were reported to exhibit various, seemingly unrelated, defects in development and RNA-mediated epigenetic heredity. Here we report a role in a distinct developmental regulation effected by a noncoding RNA. We show that Dnmt2-deficiency in mice results in cardiac hypertrophy. Echocardiographic measurements revealed that cardiac function is preserved notwithstanding the increased dimensions of the organ due to cardiomyocyte enlargement. Mechanistically, activation of the P-TEFb complex, a critical step for cardiac growth, results from increased dissociation of the negatively regulating Rn7sk non-coding RNA component in Dnmt2-deficient cells. Our data suggest that Dnmt2 plays an unexpected role for regulation of cardiac growth by modulating activity of the P-TEFb complex.

MeSH terms

  • Animals
  • Cells, Cultured
  • DNA (Cytosine-5-)-Methyltransferases / physiology*
  • Embryo, Mammalian
  • Female
  • Gene Expression Regulation, Developmental
  • Heart / embryology*
  • Heart / growth & development
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Organogenesis / genetics*
  • Positive Transcriptional Elongation Factor B / metabolism
  • RNA Polymerase II / metabolism*
  • Trans-Activators / physiology
  • Transcription, Genetic* / genetics

Substances

  • Trans-Activators
  • Dnmt2 protein, mouse
  • DNA (Cytosine-5-)-Methyltransferases
  • Positive Transcriptional Elongation Factor B
  • RNA Polymerase II

Grants and funding

This work was supported by the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE program (reference ANR-11-LABX-0028-01), the Association pour la Recherche sur le Cancer and Fondation de France (KDW), the Ligue Nationale Contre le Cancer and Agence Nationale de la Recherche France (ANR-08-GENOPAT-011 Epipath-Parapath) (MR). HG was the recipient of a scholarship from Shahid Beheshti University of Medical Sciences, Iran.